Senate Democrats warned the Trump administration against imposing additional restrictions on access to abortion pills in light of the Food and Drug Administration’s (FDA) "own review of the evidence” on the safety and effectiveness of mifepristone.

In a letter sent Thursday to FDA and the Department of Health and Human Services, Sen. Patty Murray (D-Wash.) and the entire Senate Democratic Caucus warned the agencies not to “cherry-pick junk science serving an anti-abortion agenda” as they conduct the review.

“We are alarmed by the Department’s obvious attempts to politicize the review, regulation, and approval of mifepristone at the FDA,” the Democrats wrote.

The lawmakers in the letter took issue with a recent report put out by the Ethics and Public Policy Center (EPPC), a right-wing th

See Full Page